Publications
Advancing Precision Medicine Products in the Costliest Disease Areas
Latest publications
A Novel Blood-based Assay that Predicts Clinical Response to TNFi or JAKi in Patients with Rheumatoid Arthritis
ACR 2024
11/15/2024
Development of a blood-based cell-free DNA classifier test to predict biologic and targeted synthetic DMARDs response in rheumatoid arthritis patients (PRIMA-102)
ACR 2024
11/15/2024
Extracting regulatory active chromatin footprint from cell-free DNA
Communications Biology - Nature
09/04/2024
A Novel Blood-based Assay that Predicts Clinical Response to TNFi or JAKi in Patients with Rheumatoid Arthritis
CCR East, 2024
05/08/2024
PRIMA-102: Predicting Biologic and Targeted Synthetic DMARDs Response in Rheumatoid Arthritis Patients Using a Blood Based Cell-free DNA Classifier
CCR East, 2024
05/08/2024
Detection of non-small cell lung and bladder cancer signatures in peripheral blood using a novel active chromatin capture assay
AACR 2024
04/09/2024
A Novel Blood-Based Assay Differentiates Seropositive and Seronegative Rheumatoid Arthritis From Healthy Individuals and Those With Other Inflammatory Diseases or Osteoarthritis
ACR 2023
11/15/2023
Detection of Synovial Signatures in Peripheral Blood of Patients with Rheumatoid Arthritis via a Novel Blood-Based DNA Capture Assay
ACR 2023
11/12/2023
Review of Published Literature Reporting Economic Burden of Treatment Switching in Rheumatoid Arthritis
ACR 2023
11/12/2023
Aqtual Platform Technology White Paper
01/01/2024